Bioengineering a non-genotoxic vector for genetic modification of mesenchymal stem cells

Area of Science:

• Biotechnology
• Stem Cell Biology
• Genetic Engineering

Background:

• Stem cell transfection requires non-genotoxic vectors to prevent oncogenesis.
• Existing vectors may pose risks of transforming normal stem cells into cancer-initiating cells.

Purpose of the Study:

• To bioengineer an efficient and safe vector for stem cell genetic modification.
• To assess the impact of engineered vectors on stem cell integrity and function.

Main Methods:

• Engineered targeted and non-targeted multifunctional vectors using E. coli.
• Evaluated vector efficiency, metabolic activity, membrane integrity, chromosomal aberrations, gene dysregulation, and differentiation.
• Compared engineered vectors against commercial non-viral and adenoviral vectors.

Main Results:

• The VEGFR-1 receptor-targeted vector efficiently transfected mesenchymal stem cells.
• This vector demonstrated high safety, with no induced genotoxicity or negative impact on gene function or differentiation.
• Receptor-mediated entry vectors showed superior somato- and genosafety compared to membrane-interacting vectors.

Conclusions:

• Bioengineered vectors utilizing specific receptors offer a safe and efficient method for stem cell genetic modification.
• These vectors hold promise for applications in tissue engineering and cancer therapy.
• Receptor-targeted delivery enhances the safety profile of stem cell transfection vectors.